申请人:Gruppo Lepetit, S.p.A.
公开号:US04411907A1
公开(公告)日:1983-10-25
3H-naphth[1,2-d]imidazole derivatives of formula ##STR1## wherein R stands for hydrogen, methyl or ethyl, R.sub.1 represents hydrogen, methyl or ethyl, R.sub.2 represents hydrogen, methyl, ethyl, phenyl or substituted phenyl, the symbol R.sub.3 stands for a phenyl radical optionally substituted and R.sub.4 and R.sub.5, each independently, may represent hydrogen, halogen, (C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkylthio, (C.sub.1 -C.sub.4)alkoxy or halo-(C.sub.1 -C.sub.4)alkoxy, are described. Also described is the process for preparing the novel compounds, their use as antiinflammatory agents and the pharmaceutical compositions containing them.
本申请涉及公式为##STR1##的3H-萘[1,2-d]咪唑衍生物,其中R代表氢,甲基或乙基,R.sub.1代表氢,甲基或乙基,R.sub.2代表氢,甲基,乙基,苯基或取代苯基,符号R.sub.3代表可选取代的苯基基团,R.sub.4和R.sub.5各自独立地可以表示氢,卤素,(C.sub.1-C.sub.4)烷基,(C.sub.1-C.sub.4)烷基硫醚,(C.sub.1-C.sub.4)烷氧基或卤代(C.sub.1-C.sub.4)烷氧基的化合物。还描述了制备新化合物的过程,它们作为抗炎药物的用途以及含有它们的药物组成物。